Assignee

Spirogen Sarl

Patents = 8

Forward Citations = 608

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

15 inventors (with patents filed for the assignee):

Spirogen Sarl is a biotechnology company specializing in developing targeted cancer therapies. With a focus on innovative ADC technologies, Spirogen aims to improve treatment outcomes for cancer patients through the creation of novel drugs that selectively target and destroy cancer cells, while minimizing side effects. Through strategic partnerships and collaborations, Spirogen continues to advance its pipeline of promising oncology therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com